Advertisement

Drug Therapy of Urinary Calculi and Prevention of Recurrence

  • W. Lutzeyer
  • F. Hering
Part of the Handbook of Urology book series (HDB.UROLOGY, volume 17/2)

Abstract

The disease of urolithiasis has been well documented throughout medical history, as evidenced by the finding of a calculus in the famous El Amara mummy, dating back to 4,800 B.C.

Keywords

Uric Acid Calcium Oxalate Urinary Calculus Uric Acid Stone Primary Hyperoxaluria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acker KJ van (1977) Complete deficiency of adenine phosphoribosyltransferase: Report of a family. N Engl J Med 297: 127–132PubMedCrossRefGoogle Scholar
  2. Adams DA, Goldman R, Maxwell M, Latta H (1964) Nephrotic Syndrome associated with penicillamine therapy of Wilson’s disease. Am J Med 36: 330–336PubMedCrossRefGoogle Scholar
  3. Adams TH, Norman AW (1970) Studies on the mechanism of action of calciferol I. Basic Parameters of Vit D-mediated calcium transport. J Biol Chem 245: 4421–4431PubMedGoogle Scholar
  4. Albrecht KF, Moncada F (1981) Radiographic search for renal calculi during nephrolithotomy by the Renodor-technique. In: Schulman CC (ed) Advances in diagnostic urology. Springer, Berlin Heidelberg New York, p 80Google Scholar
  5. Alken CE (1967) Die konservative Behandlung des Nierensteinleidens. Wien Klin Wochenschr 79: 657–658PubMedGoogle Scholar
  6. Alken P, Hutschenreiter G, Günther R, Marberger M (1981) Percutaneous stone manipulation. J Urol 125: 463–466PubMedGoogle Scholar
  7. Altmann RD, Johnston CC, Khairi MRA, Wellman H, Seratini AN, Saukey RR (1973) Influence of disodium etiolsonate on clinical and laboratory manifestations of Paget’s disease of bone ( Osteitis deformans ). N Engl J Med 289: 1379–1384CrossRefGoogle Scholar
  8. Anderson E, Rundles RW, Silbermann HR, Metz EN (1967) Allopurinol control of hyperuricosuria. J Urol 97: 344–347PubMedGoogle Scholar
  9. Aplas G, Schrott KM, Böwing B (1982) Ursachen, Therapie und Verlauf der Urolithiasis im Kindesalter (eine Analyse von über 170 Fällen). In: Kaufmann J (Redg von) Verhandlungsberichte der Deutschen Gesellschaft für Urologie, 33. Tagung, Köln 1981. Springer, Berlin Heidelberg New York, S 256–261Google Scholar
  10. Archer HE, Dormer AE, Slowen EF, Watts RWE (1957) Studies on the urinary excretion of oxalate by normal subjects. Clin Sci 16: 405–411PubMedGoogle Scholar
  11. Atsmon A, Vries A de, Frank M (1963) Uric acid lithiasis. Elsevier, AmsterdamGoogle Scholar
  12. Backmann U, Danielson BG, Fellström B, Johansson G, Ljunghall S, Wikström B (1981) The clinical importance of renal tubulär acidosis in recurrent renal stone formers. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 67–69Google Scholar
  13. Band RP, Silverberg DS, Henderson IF, Ulan RA, Wensel RH, Bauerjee TK, Little AS (1970) Xanthine nephropathie in a patient treated with allopurinol lymphosarcoma. N Engl J Med 283: 354–357PubMedCrossRefGoogle Scholar
  14. Bartone FF, Johnston JH (1977) Staghorn calculi in children. J Urol 118: 76–79PubMedGoogle Scholar
  15. Bass HN, Emanuel B (1966) Nephrolithiasis in childhood: Clinical and etiologic considerations. Clin Pediatr (Phila) 5: 79–85CrossRefGoogle Scholar
  16. Bass HN, Emanuel B (1966) Nephrolithiasis in childhood. J Urol 95: 749–753PubMedGoogle Scholar
  17. Baumann JM, Rutishauser G (1968) Die Behandlung der Harnsäuresteine. Ther Umsch 25: 249–254PubMedGoogle Scholar
  18. Becker BA, Swift JG (1959) Effective reduetion of the acute toxicity of certain pharmacological agents by use of synthetic ion exchange resins. Toxicol Appl Pharmacol 1: 42–54CrossRefGoogle Scholar
  19. Beer WE, Cooke KB (1967) Epidermolysis bullosa induced by penicillamine. Br J Dermatol 79: 123–125PubMedCrossRefGoogle Scholar
  20. Benedict JD, Forsham PH, Stetten D jr (1949) The metabolism of uric acid in the normal and gouty human, studied with the aid of isotopic uric acid. J Biol Chem 181: 183–193PubMedGoogle Scholar
  21. Bennet AH, Colodny AH (1973) Urinary tract calculi in children. J Urol 109: 318–320Google Scholar
  22. Berger L, Yü TF (1975) Renal function in gout IV. An analysis of 524 gouty subjects including long term follow up studies. Am J Med 59: 605–613PubMedCrossRefGoogle Scholar
  23. Bibus B (1962) Beitrag zur Zitronentherapie der Uratsteine. Urol Int 14: 28–41CrossRefGoogle Scholar
  24. Binder HJ (1974) Intestinal Oxalate absorption. Gastroenterology 67: 441–446PubMedGoogle Scholar
  25. Blacklock N, Macleod MA (1974) The effect of cellulose phosphate on intestinal absorption und urinary excretion of calcium. Br J Urol 46: 385–392PubMedCrossRefGoogle Scholar
  26. Borgmann V, Nagel R (1982) Urolithiasis im Kindesalter. In: Kaufmann J (Redg. von) Verhandlungsberichte der Deutschen Gesellschaft für Urologie, 33. Tagung, Köln 1981. Springer, Berlin Heidelberg New York, S 251–255Google Scholar
  27. Boss GR, Seegmiller JE (1979) Hyperuricemia and gout. N Engl J Med 26: 1459–1468CrossRefGoogle Scholar
  28. Boulding JE (1961) Treatment of Wilson’s disease with D-penicillamine. In: Walsh JM, Cummings JN (eds) Wilson’s disease. Some current aspects. Blackwell Scientific Publications, Oxford, p 224Google Scholar
  29. Boyce WH, Elkins IB (1974) Reconstructive renal surgery following anatrophic nephrolithotomy: Followup of 100 consecutive cases. J Urol 111: 307–312PubMedGoogle Scholar
  30. Brock WA, Nachtsheim DA, Parsons CC (1980) Hemiacridin imigation of renal pelvic calculi in patients with ideal conduit urinary diversion. J Urol 123: 345–347PubMedGoogle Scholar
  31. Bruce RR, Griffith DP (1981) Retrospective follow-up of patients with struvite calculi. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 191–193Google Scholar
  32. Budevski G (1975) Die Harnsteinbildung bei Harnwegsinfektionen in unserem Krankengut. IV. Jenaer Harnsteinsymposion, Symposiumsbericht Jena 1975, S 65–68Google Scholar
  33. Buelow H, Frohmüller H (1976) Der Rezidiv-Harnstein. Med Klin 71: 449–457Google Scholar
  34. Burghele T, Rugendorff EW, Covaliu T (1967) Zur Harnsteinprophylaxe mit Ionenaustauschern. Urologe 6: 234–238PubMedGoogle Scholar
  35. Butt AJ (1960) History of the treatment of urinary lithiasis. In: Butt AJ (ed) Treatment of urinary lithiasis. Charles C. Thomas Publisher, Springsfield III, p 3Google Scholar
  36. Campbell MF (1951) Clinical pediatric urology. Saunders, PhiladelphiaGoogle Scholar
  37. Carrod AB (1853) Gout, 2. Aufl. LondonGoogle Scholar
  38. Cartier R, Hamet M (1974) Une nouvelle maladie metabolique: Le deficit complet en adenine phosphoribosyl-transferase avec lithease de 2,8-dihydroxyadenine. CR Acad Sei 297: 883–887Google Scholar
  39. Caspary WF (1979) Oxalaturolithiasis bei gastroenterologischen Erkrankungen. Pathogenese, Klinik und Therapie. Therapiewoche 29: 2158–2165Google Scholar
  40. Cattel WR, Spencer AG, Taylor GW, Watts RWE (1962) The mechanism of the renal excretion of Oxalate in the dog. Clin Sci 22: 43–52Google Scholar
  41. Chaussy CH, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther W (1982) First clinical experience with extra-corporeally induced destruetion of kidney stones by shock waves. J Urol 127: 417–420PubMedGoogle Scholar
  42. Cifuentes-Delatte L, Castro-Mendoza H (1967) Xanthinuria familiar. Rev Clin Esp 107: 244–248PubMedGoogle Scholar
  43. Cochran M, Hodgkinson A, Zarembski PM, Anderson CU (1968) Hyperoxaluria in adults. Br JSurg 55: 121–128PubMedCrossRefGoogle Scholar
  44. Coe FL, Kavalach AG (1974) Hypercalcuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 19: 1344–1350Google Scholar
  45. Coe FL, Raisen L (1973) Allopurinol treatment of uric acid disorders in calcium stone formers. Lancet 1: 129–131PubMedCrossRefGoogle Scholar
  46. Cohanim M, Yendt ER (1981) Reduction of urinary Oxalate excretion during chronic thiazide therapy. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 235–239Google Scholar
  47. Cook DA (1975) Letter: Treament of renal stones: cellulose phosphate or magnesium. N Engl J Med 291: 1034–1035Google Scholar
  48. Corcos JM, Soler-Beghara J, Mayer K, Freyberg RH, Goldstein R, Jaffe F (1964) Neutrophilic agranulocytosis during administration of penicillamine. JAMA 189: 265–268PubMedGoogle Scholar
  49. Cram RL, Geho WR, Ray RD (1971) Diphosphonate treatment of Calcinosis universalis. N Engl J Med 285: 1012–1013PubMedCrossRefGoogle Scholar
  50. Crawhall JC, Watts RWE (1968) Cystinuria. Am J Med 45: 736–755CrossRefGoogle Scholar
  51. Crawhall JC, Scowen EF, Watts RWE (1963) Effect of penicillamine on cystinuria. Br Med J (Clin Res) 1: 588–590CrossRefGoogle Scholar
  52. Crawhall JC, Scowen EF, Thompson CJ, Watts RWE (1967) Dissolution of cystine stones during D-penicillamine treatment of a pregnant patient with cystinuria. Br Med J (Clin Res) 1: 216–221CrossRefGoogle Scholar
  53. Daeschner CW, Singleton EB, Curtis JC (1960) Urinary tract calculi and nephrocalcinosis in instants and children. J Pediatr 57: 721–724PubMedCrossRefGoogle Scholar
  54. Danielson BG (1985) Drugs against kidney stones: effects of magnesium and alkali. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York and London, pp 525–532Google Scholar
  55. Deetjen P, Boylan JW, Kramer K (1975) Physiology of the kidney and water balance. Springer, New York Heidelberg BerlinGoogle Scholar
  56. Dempsey E, Caroll EL, Albright F, Hennemann PH (1958) A study of factors determining fecal electrolyt excretion. Metabolism 7: 108–114PubMedGoogle Scholar
  57. Dent CE, Philpot GR (1954) Xanthinuria, an inborn error (or deviation) of metabolism. Lancet 1: 182–185CrossRefGoogle Scholar
  58. Dent CE, Senior B (1955) Studies on the treatment of cystinuria. Br J Urol 27: 317–332PubMedCrossRefGoogle Scholar
  59. Dent CE, Harper CM, Parfitt AG (1964) The effect of cellulose phosphate on calcium metabolism in patients with hypercalciuria. Clin Sei 27: 417–425PubMedGoogle Scholar
  60. Dirks IH, Onamme GA, Sutton RAL (1976) Filtration and Reabsorption von Kalzium in der Niere. Internationales Harnsteinsymposion, Davos 1976. In: Feldmann U, Mewes D (Hrsg) Urolithiasis. Straube, Erlangen, S 26–28Google Scholar
  61. Dirks J (1984) Renal handling of calcium. Vth International Symposion on urolithiasis and related clinical research, Garmisch-PartenkirchenGoogle Scholar
  62. Dock W, Frank NR (1950) Cation exchangers: Their use and hazards as aids in managing edema. Am Heart J 40: 638–645PubMedCrossRefGoogle Scholar
  63. Dosch W (1976) Ionenaustauscher. Symposion Nierensteinleiden, München 1976Google Scholar
  64. Dosch W (1978) Mineralogische Grundlagen der Harnsteinbildung. Med Welt 29: 39–43PubMedGoogle Scholar
  65. Duarte CG, Bland JH (1965) Changes in metabolism of calcium, phosphorus and uric acid after oral administration of chlorothiazide. Metabolism 14: 899–903PubMedCrossRefGoogle Scholar
  66. Dulce HJ (1965) Die Phosphattherapie des Harnsteinleidens. Urologe 4: 163–164PubMedGoogle Scholar
  67. Dulce HJ, Dulce MC, Butz M (in Druck) Einfluß von Säure- und Basenbelastung auf Harnzusammensetzung und Löslichkeitsverhältnisse. In: Gasser G, Vahlensieck W (Hrsg) Klinik und Pathogenese der Harnsteine, Harnsteinsymposion Bonn—Wien, XI. Symposion, Wien, 21.-23. 3. 85, Steinkopff, DarmstadtGoogle Scholar
  68. Earnest DL, Johnson G, Williams HE, Admirand WH (1974) Hyperoxaluria in patients with ileal resection. An abnormality in dietary Oxalate absorption. Gastroenterology 66: 1114–1122PubMedGoogle Scholar
  69. Edwards NA, Russel RGG, Hodgkinson A (1965) The effect of oral phosphate in patients with recurrent renal calculus. Br J Urol 37: 390–398PubMedCrossRefGoogle Scholar
  70. Eisenberger F, Schmiedt E, Peifer KJ, Chaussy Ch, Rothe R, Klein V, Reidl P (1973) In-situ- Perfusion und Kühlung der Niere bei Ausgußsteinen. Münch Med Wochenschr 115: 404–409PubMedGoogle Scholar
  71. Elder TD, Wyngaarden JB (1960) The biosynthesis and turnover of oxalic acid in normal and hyperoxaluria subjects. J Clin Invest 39: 1337–1344PubMedCrossRefGoogle Scholar
  72. Elefant E, Brodsky M, Jelinek J (1966) Urolithiasis in infants. Ann Pediatr (Basel) 199: 581–587Google Scholar
  73. Elliot JS, Ribeiro ME (1970) Magnesium and calcium Oxalate solubility. Invest Urol 8: 396–390Google Scholar
  74. Engelmann K, Watts RWE, Klinenberg JP, Sjoerdsma A, Seegmiller JE (1964) Clinical, physiological and biochemical studies of a patient with xanthinuria and pheochromocytoma. Am J Med 37: 839–861CrossRefGoogle Scholar
  75. Ettinger B (1976) Recurrent nephrolithiasis: Natural history and effect of phosphat therapy. Am J Med 61: 200–206PubMedCrossRefGoogle Scholar
  76. Ettinger B (1976) Recurrent nephrolithiasis: Natural history and effect of phosphate therapy. JAMA 61: 200–206Google Scholar
  77. Fam B, Rossier AB, Yalla S, Berg S (1976) The role of hemiacridin in the management of renal stones in spinal cord injury patients. J Urol 48: 531–537CrossRefGoogle Scholar
  78. Fawcett NP, Nyhan WL, Anderson WW (1966) Thrombocytosis during treatment of cystinuria with penicillamine. J Pediatr 69: 976–979Google Scholar
  79. Fellström B (1985) Allopurinol treatment in urolithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research act, Plenum Press, New York and London, pp 505–512Google Scholar
  80. Felts JH, King JS, Boyce WH (1968) Nephrotic Syndrome after treatment with penicillamine. Lancet 1: 53–54PubMedCrossRefGoogle Scholar
  81. Finlayson B (1974) Renal lithiasis in review. Symposion on renal lithiasis. Urol Clin North Am 1: 181–211PubMedGoogle Scholar
  82. Fishbeim WN (1981) Urease inhibitors in the treatment of infection induced stones: Some chemical, pharmacologic and clinical considerations. In: Smith CH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 209–214Google Scholar
  83. Fitzpatrick JM, Marberger M, Wickham JEA (1981) A study of the effectiveness of inosine in renal transplantation. Eur Urol 7: 16–18PubMedGoogle Scholar
  84. Flanagan TL, Sax MF, Heming AE (1951) Toxicity studies on amberlite XE-96, a carboxylic type cation exchanger resin. J Pharmacol Exp Ther 103: 215–222PubMedGoogle Scholar
  85. Fleisch H, Bisaz S (1961) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203: 671–678Google Scholar
  86. Fleisch H, Bisaz S (1966) Pathophysiologie der Urolithiasis. Z Urol 59: 785–791Google Scholar
  87. Fleisch H, Rüssel RGG, Bisaz S, Mühlbauer RC, Williams DA (1970) The inhibitory effect of phosphonates on the formation of calcium phosphate crystal in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1: 12–18PubMedCrossRefGoogle Scholar
  88. Garrod AB (1853) Nature and treatment of gout and rheumatic gout, 2nd edn. LondonGoogle Scholar
  89. Gebhardt M, Bastian HP (1976) Harnsteingruppierung und Analysengenauigkeit. Urol Int 31: 217–229PubMedCrossRefGoogle Scholar
  90. Genot R (1956) Nor moyen d’action sur hypercalcurie des lithiase urinaires. Semin Hop (Paris) 32: 2978Google Scholar
  91. Gershoff SN (1964) Vitamin B6 and Oxalate metabolism. Vitam Horm 22: 581–589PubMedCrossRefGoogle Scholar
  92. Gil-Vernet J (1965) New surgical concepts in removing renal calculi. Urol Int 20: 255–259PubMedCrossRefGoogle Scholar
  93. Gil-Vernet JM (1981) Three-dimensional radiography of the kidney. In: Schulman CC (ed) Advances in diagnostic urology. Springer, Berlin Heidelberg New York, p 87–100Google Scholar
  94. Glazenburg J (1972) The effect of hydrochlorothiazide on the renal excretion of oxalic acid and on the formation of Oxalate stone in the urinary tract. Archivum Chirurgicum Neder- landicum 23: 217–223Google Scholar
  95. Godfrey RG, Rankin TJ (1969) Uric acid renal lithiasis: Management by allopurinol. J Urol 101: 643–647PubMedGoogle Scholar
  96. Goldberg A, Smith JA, Lockhead A (1963) Treatment of lead poisoning with oral penicillamine. Br Med J 1: 1270–1275PubMedCrossRefGoogle Scholar
  97. Green NA, Shaw AB (1981) Bladder stones in children. The Norwich School of Lithotomy. Eur Urol 3: 126–131Google Scholar
  98. Griffith DP (1978) Struvite stones. Kidney Int 13: 372–382PubMedCrossRefGoogle Scholar
  99. Griffith DP, Musher DM, Campbell JW (1973) Inhibition of bacterial urease. Invest Urol 11: 234–238PubMedGoogle Scholar
  100. Griffith DP, Musher DM, Itin Ch (1976) Urease. The primary cause of infection induced urinary stones. Invest Urol 13: 346–350Google Scholar
  101. Griffith DP, Gibson JR, Clinton CW, Musher DM (1978) Acetohydroxamine acid: Clinical studies of a urease inhibitor in patients with staghorn renal calculi. J Urol 119: 9–15PubMedGoogle Scholar
  102. Griffith DP, Moskowitz P, Feldman S (1981) Infection, induced stones: Status of clinical trials with Urostat™ (Acetohydroxamic acid). In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 199–208Google Scholar
  103. Gutman AB, Yü TF (1957) Renal function in gout with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 23: 600–608PubMedCrossRefGoogle Scholar
  104. Gutman AB, Yü TF (1968) Uric acid nephrolithiasis. Am J Med 45: 756–759PubMedCrossRefGoogle Scholar
  105. Hagmaier V, Werness P, Smith LH (1984) Enteric hyperoxaluria: Risk factors for urolithiasis in addition to hyperoxaluria. In: Ryall R, Brockis JG, Marshall V, Finlayson B (eds) Urinary Stone, Churchill Livingstone, Melbourne—New York, pp 241–247Google Scholar
  106. Hallson PC, Rose GA, Samuell CT (1981) Inhibitors of calcium oxalate and calcium phosphate crystal formation in urine — a critique and reappraisal. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 589–600Google Scholar
  107. Hammarsten G (1928) On calcium Oxalate and its solubility in the presence of inorganic salts with special reference to the occurrence of oxaluria. CR Lab Carlsberg 17: 1–36Google Scholar
  108. Hammarsten G (1929) On calcium Oxalate and its solubility in the presence of inorganic salts with special reference to the occurence of oxaluria. CR Trav Lab Carlsberg 17: 1–85Google Scholar
  109. Harris H, Mittwoch U, Robson EB, Warren FL (1955) Phenotypes and genotypes in cystinuria. Ann Hum Genet 20: 57–61PubMedCrossRefGoogle Scholar
  110. Harrison HE, Harrison HC (1963) Sodium, potassium and intestinal transport of glucose, 1-tyrosine phosphate and calcium. Am J Physiol 205: 107–111PubMedGoogle Scholar
  111. Hartung R (1975) Die Bedeutung der Harnsäure bei der Kalziumoxalatnephrolithiasis. Münch Med Wochenschr 117: 387–390Google Scholar
  112. Hartung R, Leskovar P, Allgayer R, Schneider H, Bender O, Wellnhofer E, Simmel M (1981) Inhibited precipitation and growth of calcium oxalate crystals in the presence of alkaline salts of some polyhydroxycarboxylic acids. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 663–667Google Scholar
  113. Hatch M, Bourke E, Costello J (1977) New enzymic method for serum Oxalate determination. Clin Chem 23: 76PubMedGoogle Scholar
  114. Hauser W, Frick J (in Druck) Erste Ergebnisse einer Metaphylaxe mit Natrium-Kalium-Zitrat an rezidivierenden Kalziumoxalatsteinträgern. In: Gasser G, Vahlensieck W (Hrsg) Klinik und Pathogenese der Harnsteine. Harnsteinsymposion Bonn—Wien, XI. Symposion, Wien, 21.–23. 3. 85. Steinkopff, DarmstadtGoogle Scholar
  115. Haussler M, Hughes M, Baylink D, Littledike ET, Cork D, Pitt M (1977) Influence of phosphate depletion on the biosynthesis and circulating level of 1-alpha, 2,5 dihydroxyvitamin D. In: Massry SG, Ritz E (eds) Phosphate metabolism. Plenum Press, New York, p 233–250Google Scholar
  116. Hautmann R (1980) Oxalatstoffwechsel, Hyperoxalurie, Oxalose. In: Hautmann R, Lutzeyer W (Hrsg) Harnsteinfibel. Deutscher Ärzteverlag, Köln, S 62–71Google Scholar
  117. Hautmann R, Terhorst B, Stuhlsatz HW, Lutzeyer W (1977) Mercaptopropionylglycine: A progress in cystine stone therapy. J Urol 117: 628–630PubMedGoogle Scholar
  118. Hautmann R, Hering F, Lutzeyer W (1978) Effects and side effects of cellulose phosphate and succinate in long term treatment of hypercalcuria or hyperoxaluria. J Urol 120: 712–715PubMedGoogle Scholar
  119. Hayashi Y, Kaplan RA, Pak CYC (1975) Effect of sodium cellulose phosphate therapy on crystallization of calcium Oxalate in urine. Metabolism 24: 1273–1278PubMedCrossRefGoogle Scholar
  120. Heidbreder E, Hennemann H, Krempien B, Heidland A (1972) Solidiaretische Behandlung der renal-tubulären Azidose und ihrer Komplikationen. Dtsch Med Wochenschr 97: 1504–1507PubMedCrossRefGoogle Scholar
  121. Helbig W, Findeisen B (1971) Serum- und Harngehalt bei Haemoblastosen und Gicht sowie seine Beeinflussung durch Allopurinol. Z Inn Med 26: 233–237Google Scholar
  122. Hering F (1980) Spezielle Maßnahmen beim Harnsäurestein. In: Hautmann R, Lutzeyer W (Hrsg) Harnsteinfibel. Deutscher Ärzteverlag, Köln, S 156–159Google Scholar
  123. Hering F, Lutzeyer W (1979) Resorptive and absorptive hypercalcuria. Therapy with sodium cellulose phosphate or thiazides. Eur Urol 5: 29–31Google Scholar
  124. Hering F, Hautmann R, Lutzeyer W (1979) Wirksamkeit und Nebenwirkungen einer differenzierten Hypercalciurie-Therapie. Ein Vergleich zwischen Thiaziden, Natrium-Cellulosephosphat, Campanyl und deren Kombination. In: Gasser G, Vahlensieck W (Hrsg) Fortschritte der Urologie und Nephrologie, Bd 14, Pathogenese und Klinik der Harnsteine V II. Steinkopff, DarmstadtGoogle Scholar
  125. Hering F, Nowak H, Lutzeyer W (1980) Neues Konzept der Harnsteinprophylaxe - Computerprogramm zur Kalkulation des Löslichkeitsproduktes im Harn. In: Frohmüller H (Redg von) Verhandlungsberichte der Deutschen Gesellschaft für Urologie, 31. Tagung, München 1979. Springer, Berlin Heidelberg New York, S 474–475Google Scholar
  126. Hering F, Burschard G, Pyhel N (1981) The relation between relative supersaturation and crystal aggregation in urine — a SEM study and a computerized calculation of the ion equilibrium. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 441–445Google Scholar
  127. Hering F, Frank M, Lutzeyer W (1981) Urolithiasis im Kindesalter. In: Frohmüller H (Redg von) Verhandlungsberichte der Deutschen Gesellschaft für Urologie, 32. Tagung, Berlin 1980. Springer, Berlin Heidelberg New York, S 274–277Google Scholar
  128. Herring LC (1962) Observations on the analysis of 10,000 urinary calculi. J Urol 88: 545–562PubMedGoogle Scholar
  129. Hesse A, Böhmer I, Classen A, Vahlensieck W (in Druck) Steigerung der inhibitorischen Wirkung des Harns durch Verabreichung eines Natrium-Kalium-Zitrat-Gemisches (Oxalyt C) In: Gasser G, Vahlensieck W (Hrsg) Klinik und Pathogenese der Harnsteine. Harnsteinsymposion Bonn-Wien, XI. Symposion, Wien, 21.–23. 3. 85. Steinkopff, DarmstadtGoogle Scholar
  130. Hodgkinson A (1977) Oxalic acid in biology and medicine. Academic Press, London New York San FranciscoGoogle Scholar
  131. Hodgkinson A, Zarembski PM (1968) Oxalic acid metabolism: A review. Calcif Tissue Res 2: 115–132PubMedCrossRefGoogle Scholar
  132. Hodgkinson A, Wilkinson R, Nordin BEC (1973) The concentration of oxalic acid in human blood. In: Delatte LC, Rapado A, Hodgkinson A (eds) Urinary calculi. Karger, Basel, p 18–23Google Scholar
  133. Hodgkinson A, Bisset P, Tye J (1975) Effect of succinimide and other drugs on Oxalate excretion by rats. Urol Int 30: 465–471PubMedCrossRefGoogle Scholar
  134. Holländer E, Schwarczmann P (1969) Hemmung der endogenen Harnsäuresynthese mit Allopurinol. Münch Med Wochenschr 111: 1623–1626PubMedGoogle Scholar
  135. Horn HD (1971) Basis-Diagnostik und konservative Therapie bei Kranken mit Kalziumstein-Diathese. Dtsch Med J 21: 506–512Google Scholar
  136. Howard JE, Thomas WC (1968) Control of crystallization in urine. Am J Med 45: 693–699PubMedCrossRefGoogle Scholar
  137. Hutschenreiter G, Riedmiller H, Thüroff J, Alken P (1982) Intraoperative, sonographische Sternlokalisation und dopplergesteuerte Nephrotomie — das Ende von Ischaemie und Kühlung. In: Kaufmann J (Redg von) Verhandlungsberichte der Deutschen Gesellschaft für Urologie, 33. Tagung, Köln 1981. Springer, Berlin Heidelberg New York, S 357Google Scholar
  138. Jacobs STC, Gittes RF (1976) Dissolution of residual renal calculi with hemiacridin. J Urol 115: 2–4PubMedGoogle Scholar
  139. Jacobson AL, Singhai PC, Mandin H, Hyne JB (1979) Urinary ionic calcium and binding sites in normocalciuric idiopathic calcium urolithiasis. Invest Urol 17: 218–222PubMedGoogle Scholar
  140. Jaffe IA, Altmann K, Merryman P (1964) The antipyridoxin effect of penicillamine in man. J Clin Invest 43: 1869–1873PubMedCrossRefGoogle Scholar
  141. Johansson G, Backman U, Danielson BG, Fellström B, Ljunghall S, Wikström B (1981) Prophylactic treatment with magnesium hydroxide in renal stone disease. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 267–273Google Scholar
  142. Johnston JH (1973) Etiologic puzzle: Calculous disease in children. Med World News (Urology) 15Google Scholar
  143. Kallistratos G (1972) Physicochemical principles and clinical results concerning the conservative treatment of kidney stones in urinary calculi. International Symposion renal stone research, Madrid 1972, p 198–205Google Scholar
  144. Katz R (1967) Penicillamine-induced skin lesion, a possible example of human lathyrism. Arch Dermatol 95: 196–198PubMedCrossRefGoogle Scholar
  145. Keiser HR, Henkin RI, Bartter FC, Sjoerdsma A (1968) Loss of taste during therapy with penicillamine. JAMA 203: 381–383PubMedCrossRefGoogle Scholar
  146. Kelley WN, Rosenbloom FM, Miller J, Seegmiller JE (1968) An enzymatic basis for Variation in response to allopurinol. Hypoxanthine–guanine-phosphoriboxyltransferase deficiency. N Engl J Med 278: 287–293PubMedCrossRefGoogle Scholar
  147. King JS jr (1969) Treatment of cystinuria with alpha-mercaptopropionylglycine. A preliminary report with some notes on calcium chromatography of mercaptants. Proc Soc Exp Biol Med 129: 927–932Google Scholar
  148. King JS (1971) Currents in renal stone research. Clin Chem 17: 971–982PubMedGoogle Scholar
  149. King JS, Boyce WH (1965) Effect of penicillamine on cystinuria. Invest Urol 2: 595–597PubMedGoogle Scholar
  150. Kinoschita K, Yachiku S, Takenhi N, Kotake T, Sonoda T (1972) Treatment of cystinuria with alpha-mercaptopropionylglycine. Proceedings 2nd International Symposion on Thiola, Sauten, Osaka 1972, p 50–54Google Scholar
  151. Klauwers J, Wolf PL, Cohn R (1969) Failure of renal transplantation in primary oxalosis. JAMA 205: 551CrossRefGoogle Scholar
  152. Kohler FP (1962) Renacidin and tissue reaction. J Urol 87: 102–108PubMedGoogle Scholar
  153. Kolb FO, Earll JM, Harper HA (1967) Disappearance of cystinuria in a patient treated with prolonged low methionine diet. Metabolism 16: 378–381PubMedCrossRefGoogle Scholar
  154. Kollwitz AA, Brauer R (1968) Die Harnsäuresteinbildung aus der Sicht des Urologen. Urol Int 23: 411–427PubMedCrossRefGoogle Scholar
  155. Krakoff IH, Meyer RL (1965) Prevention of hyperuricemia in leukemia and lymphoma. Use of allopurinol, a xanthine oxidase inhibitor. JAMA 193: 1–6PubMedGoogle Scholar
  156. Lattimer JU, Hubbard M (1951) Pediatric urological admissions. J Urol 66: 89–93Google Scholar
  157. Lesch M, Nyhan WL (1964) A familial disorder of uric acid metabolism and central nervous system function. Am J Med 39: 561–570CrossRefGoogle Scholar
  158. Lichtwitz A, Parlier R, Seze S de, Hioco D, Miravet L (1961) L’effet hypocalcin reque des Sulfonamides duretiques. Sem Hop Paris 37: 2350–2362Google Scholar
  159. Ljunghall S, Backmann U, Danielson RG, Fellström B, Johansson G, Willström B (1981) Long-term treatment with bendroflumethiazide for prevent of stones. Metabolie effects. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 245–248Google Scholar
  160. Lotz M, Potts JT (1964) Quantitation of the effects of penicillamin therapy in cystinuria. J Clin Invest 43: 1293–1296Google Scholar
  161. Lotz M, Potts JT, Bartter FC (1965) Recent advances in the therapy of cystinuria. Milit Med 130: 768–774Google Scholar
  162. Lotz M, Potts JT, Holland JM, Kieser WS, Bartter FC (1966) D-penicillamine therapy in cystinuria. J Urol 95: 257–261PubMedGoogle Scholar
  163. Luca HF de (1979) Vitamin D metabolism and function. Springer, Berlin Heidelberg New YorkGoogle Scholar
  164. Lytton B (1979) Surgery of the kidney. In: Harrison JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC (eds) Campbell’s urology. Saunders, Philadelphia London Toronto, p 1993–2046Google Scholar
  165. Lytton B, Glazier WB, Chudry IH, Bane AE (1979) The use of ATP-Mg Cl2 in the treatment of post-ischemic renal injury. Trans Am Assoc Gen Surg 70: 145–148Google Scholar
  166. MacDonald WB, Fellers FX (1966) Penicillamine in the treatment of patients with cystinuria. JAMA 197: 396–402PubMedCrossRefGoogle Scholar
  167. Malek RS, Kelalis PP (1975) Pediatric nephrolithiasis. J Urol 113: 545–551PubMedGoogle Scholar
  168. Malluche HH, Tschöpe W, Ritz E, Meyer W, Massry S (1981) Disturbed terminal mineralisation of bone in idiopathic hypercalcuria. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 841–845Google Scholar
  169. Mandel NS, Mandel GS (1981) Epitaxis between stone-forming crystals at the atomic level. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York, p 469–480Google Scholar
  170. Marberger M, Eisenberger F (1980) Regional hypothermia of the kidney: Surface or transarterial cooling? A functional study. J Urol 124: 179–183PubMedGoogle Scholar
  171. Marberger M, Stackl W (1981) Renal hypothermia in situ. In: Resnick MI (ed) Current trend in urology, vol 1. William and Wilkins, Baltimore London, p 70–76Google Scholar
  172. Marberger M, Günter R, Mayer EJ, Wiestier MA (1976) A simple method for in situ preservation of the ischemic kidney during renal surgery. Invest Urol 14: 191–193PubMedGoogle Scholar
  173. Marberger M, Stackl W, Hruby W (1982) Percutaneous litholapaxy of renal calculi with ultrasound. Eur Urol 8: 236–242PubMedGoogle Scholar
  174. Marget A (1817) An essay on chemical history and medical treatment of calculus disorders. LondonGoogle Scholar
  175. Marquardt H, Nagel R (1977) Das Harnsteinleiden im Kindesalter. 19. Nordd. Urologentag, Braunlage 1977Google Scholar
  176. Martin DL, Luca HF de (1969) Calcium transport and the role of vitamin D. Arch Biochem Biophys 134: 139–148PubMedCrossRefGoogle Scholar
  177. May P, Braun J (in Druck) Zitratausscheidung rezidivierender Kalziumoxalatsteinbildner vor und während einer alkalisierenden Behandlung. In: Gasser G, Vahlensieck W (Hrsg) Klinik und Pathogenese der Harnsteine. Harnsteinsymposion Bonn-Wien, XI. Symposion, Wien, 21.-23. 3. 85. Steinkopff, DarmstadtGoogle Scholar
  178. McChesney EW, McAuliff JP (1950) Effects of some ion exchange resins on the mineral metabolism of rats. Am J Physiol 160: 164–276Google Scholar
  179. McDonald JE, Henneman PH (1965) Stone dissolution in vivo and control of cystinuria with D-penicillamine. N Engl J Med 273: 578–584PubMedCrossRefGoogle Scholar
  180. Melchior H, Lang G (1981) Three-dimensional intraoperative stone localisation. In: Schulman CC (ed) Advances in diagnostic urology. Springer, Berlin Heidelberg New York, p 101–105Google Scholar
  181. Melnick I, Landes RR, Hoffman AA, Burch JF (1971) Magnesium therapy for recurring calcium Oxalate urinary calculi. J Urol 105: 119–122PubMedGoogle Scholar
  182. Miano L, Galluci M, Petta S (1976) Dissoluzione di litiasi renale cistiniar mediante terapia medica. Prog Med 32: 207–212Google Scholar
  183. Miano L, Galluci M, Petta S (1979a) Results of medical treatment of cystine lithiasis. Eur Urol 5: 265–272PubMedGoogle Scholar
  184. Millis RM (1971) Severe hypersensitivity reactions associated with allopurinol. JAMA 3: 799–802CrossRefGoogle Scholar
  185. Minkov N, Konstantinov D, Gatser G (1981) Urolithiasis in children. Eur Urol 3: 132–133Google Scholar
  186. Mitchel JP (1981) Lithiasis in children. Eur Urol 3: 121–124Google Scholar
  187. Mulvaney WP (1960) Clinical use of renacidin in urinary calcifications. J Urol 84: 206–212PubMedGoogle Scholar
  188. Myers NA (1957) Urolithiasis in childhood. Arch Dis Child 32: 48–54PubMedCrossRefGoogle Scholar
  189. Nemoy NJ, Stamey ThA (1976) Use of hemiacridin in management of infection stones. J Urol 116: 693–695PubMedGoogle Scholar
  190. Nicolayson R (1937) Studies upon the mode of action of vitamin D. II. The influence of vitamin D on the faecal Output of endogenous calcium and phosphorus in the rat. Biochem J 31: 106–113Google Scholar
  191. Nishimura R, Ishido T, Takai S (1970) Effect of alpha-mercaptopropionylglycine. Proceedings 1st International Symposion on Thiola, Sauten, Osaka 1970, p 235–237Google Scholar
  192. Nishimura R, Ishido T, Takai S (1972) Studies on cystinuria. Proceedings 2nd International Symposion on Thiola, Sauten, Osaka 1972, p 47–49Google Scholar
  193. Nordin BEC (1976) Calcium phosphate and magnesium metabolism. Churchill–Livingstone, EdinburghGoogle Scholar
  194. Osler W (1912) Section XI nephrolithiasis. The principles and practice of medicine. Appleton, Oxford, p 717Google Scholar
  195. Pak CYC (1972) Effects of cellulose phosphate and sodium phosphate on formation product and activity product of brushite in urine. Metabolism 21: 447–455PubMedCrossRefGoogle Scholar
  196. Pak CYC (1973) Sodium cellulose phosphate. Mechanism of action and effect on mineral metabolism. J Clin Pharmacol 13: 15–27Google Scholar
  197. Pak CYC (1973) Hydrochlorothiazide therapy in nephrolithiasis: Effect on urinary activity product and formation product of brushite. Clin Pharmacol Ther 14: 209–217PubMedGoogle Scholar
  198. Pak CYC (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalcuries. N Engl J Med 292: 497–500PubMedCrossRefGoogle Scholar
  199. Pak CYC, Arnold LH (1975) Heterogenous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149: 930–952PubMedGoogle Scholar
  200. Pak CYC, Peacock M (1984) Need for Classification of calciurias in stone patients—pros. and cons. Vth International Symposion on urolithiasis and related clinical research, Garmisch-PartenkirchenGoogle Scholar
  201. Pak CYC, Cox JW, Powel E, Barter FC (1971) Effect of oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine. Am J Med 50: 67–76PubMedCrossRefGoogle Scholar
  202. Pak CYC, Delen CS, Bartter FC (1974) Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N Engl J Med 290: 175–180PubMedCrossRefGoogle Scholar
  203. Pak CYC, Tolentino R, Stewart A, Galosy RA (1978) Enhancement of renal excretion of uric acid during long term thiazide therapy. Invest Urol 16: 191–193PubMedGoogle Scholar
  204. Parfitt AM, Higgins BA, Nassim JR, Collins JA, Hilf A (1964) Metabolic studies in patients with hypercalcuria. Clin Sei 27: 463–482PubMedGoogle Scholar
  205. Pavanello L, Rizzoni G, Dussini N, Zaccello G, Passerini G, Tasca A, Pagano F (1981) Cystinuria in children. Eur Urol 3: 139–143Google Scholar
  206. Pietrek J, Kokot F (1973) Treatment of patients with calcium containing renal stones with cellulose phosphate. Br J Urol 45: 136–143PubMedCrossRefGoogle Scholar
  207. Pinto B, Bernshtam J (1978) Diethylaminoethanol-cellulose in the treatment of absorptive hyperoxaluria. J Urol 119: 630–632PubMedGoogle Scholar
  208. Pinto B, Pujol J (1981) Identification of a small molecular weight inhibitor of the Oxalate precipitation. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 637–639Google Scholar
  209. Potter CF, Cadenhead A, Simmonds HA, Cameron JS (1979) Differential absorption of purine nucleosides and bases. In: Rapado A, Watts RWE, Bruyn CHMM de (eds) Purine metabolism. Plenum Press, New York LondonGoogle Scholar
  210. Prien EL (1955) Studies in urolithiasis. J Urol 73: 627–652PubMedGoogle Scholar
  211. Prien EL (1963) Crystallographic analysis of urinary calculi: A 23-year survey study. J Urol 89: 917–924PubMedGoogle Scholar
  212. Prien ES, Gershoff SF (1974) Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi. J Urol 112: 509–512PubMedGoogle Scholar
  213. Rapado A (1970) Treatment of idiopathic hypercalcuria with sodium cellulose phosphate. Rev Clin Esp 119: 61–68PubMedGoogle Scholar
  214. Rapado A, Calle H de la, Castrillo JM, Mancha A, Traba ML, Cifuentes-Delatte L (1976) Nephrolithiasis bei Hypercalcurie und Hyperparathyreoidismus. Münch Med Wochenschr 118: 799–804Google Scholar
  215. Remieen A, Kallistratos G, Burchardt P (1975) Treatment of cystinuria with thiola (alpha-mercaptopropionylgylcine). Eur Urol 1: 227–230Google Scholar
  216. Riedmiller H, Thüroff J, Alken P, Hutschenreiter G, Hohenfellner R (1981) Gefäß- und Steinlokalisation durch Ultraschall—das Ende von Ischämie und Kühlung in der Nierensteinchirurgie? Akt Urol 12: 210–215CrossRefGoogle Scholar
  217. Ries SW, Malament M (1962) Renacidin: A urinary calculus solvent. J Urol 87: 657–661PubMedGoogle Scholar
  218. Riet B van’t, O’Rear CE (1981) Interaction of dyes with inorganic constituents of kidney stones. In: Smith LH, Robertson WE, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 669–672Google Scholar
  219. Robertson WG (1976) Urinary excretion. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Churchill-Livingstone, Edinburgh, p 113–161Google Scholar
  220. Robertson WG, Knowles F, Peacock M (1976) Urinary acid mucopolysaccarides inhibitors of calcium oxalate crystallisation. In: Fleisch H (ed) Urolithiasis research. Plenum Press, New York London, p 331Google Scholar
  221. Robertson WG, Peacock M, Heyburn PJ, Rutherford A, Sergeant VJ, Bambach CP (1981a) A risk factor model of stone-formation: Application to the study of epidemiological factors in the genesis of calcium stones. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 303–307Google Scholar
  222. Robertson WG, Peacock M, Ouiment D, Heyburn PJ, Rutherford A (1981b) The main risk factor for calcium Oxalate stone disease in man: Hypercalcuria or mild hyperoxaluria. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 3–12Google Scholar
  223. Robertson WG, Peacock M (1985) Pathogenesis of Urolithiasis. In: Schneider H-J (Ed) Urolithiasis: Etiology, Diagnosis. Springer, Berlin Heidelberg New York Tokyo (Handbook of Urology, Vol. 17 /1, p 185–334 )Google Scholar
  224. Rodgers A, Garside J (1981) The effect of some urinary constituents on the in vitro nucleation and growth kinetics of calcium Oxalate. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 641–650Google Scholar
  225. Rodman J (1984) Secondary urolithiasis. Vth International Symposion on urolithiasis and related research, Garmisch-PartenkirchenGoogle Scholar
  226. Rose GA, Harrison AR (1974) The incidence, investigation and treatment of idopathic hypercalcuria. Br J Urol 46: 261–274PubMedCrossRefGoogle Scholar
  227. Rosemberg LE, Hayslett JP (1967) Nephrotoxic effects of penicillamine in cystinuria. JAMA 201: 698–700CrossRefGoogle Scholar
  228. Rugendorff EW, Schneider HJ, Hallwachs O (1981) Long term effects of campanyl in the treatment of patients with calcium urinary stone. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 283–286Google Scholar
  229. Rundles RW, Wyngaarden JB, Hitchings GH, Ellion GB, Silberman HR (1963) Effect of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Tr A Am Physicians 76: 126–130Google Scholar
  230. Ryall RL, Marshall VR (1981) The effect of normal and stone forming urine on the growth and aggregation of calcium oxalate crystals in relation to urinary glycosaminoglycans and urate concentrations. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 611–618Google Scholar
  231. Sallis JD, Bichler KH, Korn S, Haussmann A (1981) Urinary glycosaminoglycan excretion in patients with urolithiasis. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 619–622Google Scholar
  232. Samberger N, Braun J, Lux B, May P (1979) Harnsäuresteinbildung und Uratverstopfung der ableitenden Harnwege durch Urikosurika. Akt Urol 10: 21–26Google Scholar
  233. Schachter D, Rosen SM (1959) Active transport of Ca45 by the small intestine and its dependence an vitamin D. Am J Physiol 196: 357–359PubMedGoogle Scholar
  234. Schneider HJ (1979) Epidemiologische Aspekte der Urolithiasis. Urologe [Ausg B] 19: 54–61Google Scholar
  235. Schneider HJ (1980) Spezielle Maßnahmen der Therapie und Prophylaxe bei Infektsteinen. In: Hautmann R, Lutzeyer W (Hrsg) Harnsteinfibel. Deutscher Ärzteverlag, Köln, S 181–190Google Scholar
  236. Schneider HJ, Klotz L, Horn G (1969) Die Herstellung eines Zitratgranulats und seine Verwendung in der Therapie der Harnsäurelithiasis. Z Urol Nephrol 62: 351–355PubMedGoogle Scholar
  237. Scholz D, Schwille PO, Sigel A (1981) Experience with thiazides in a double blind study. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 249–252Google Scholar
  238. Schrier EE, Rubin JL, Lee KE, Werness PG, Smith LH (1981) Characterization of the calcium oxalate crystal growth inhibitors in human urine. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 579–588Google Scholar
  239. Schulte KE, Rendic S, Henke G, Mrongovius RJ (1979) Pharmacokinetics and disposition of orally administered 3,4-C14 succinimide in the rat. Vortrag Arbeitstagung Succinimid, Iserlohn 1979Google Scholar
  240. Schwille PO (in Druck) Orales Alkali-Zitrat bei Gesunden—Ergebnisse einer Dosis-Wirkungsstudie. In: Gasser G, Vahlensieck W (Hrsg) Klinik und Pathogenese der Harnsteine. Harnsteinsymposion Bonn—Wien, XI. Symposion, Wien, 21.-23. 3. 85. Steinkopff, DarmstadtGoogle Scholar
  241. Scott JT, Holloway VP, Glass HI (1966) Studies of uric acid pool and turn over rate. Am Rheum Dis 38: 366–373Google Scholar
  242. Scott R, Patterson PJ, Smith M, Mathiesen A (1979) Reduction in urinary oxalate values by allopurinol. Urology 12: 212–214CrossRefGoogle Scholar
  243. Scultety S, Balogh ES (1967) Zur Auflösung und Prophylaxe der Uratsteine. Z Urol Nephrol 60: 843–852PubMedGoogle Scholar
  244. Scurr DS, Bridge CM, Robertson WG (1981) Studies on inhibitors and promoters of the crystallization of calcium oxalate in urine and in matrix from calcium Oxalate stones. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 601–605Google Scholar
  245. Seegmiller JE (1968) Xanthine stone formation. Am J Med 45: 780–783PubMedCrossRefGoogle Scholar
  246. Seegmiller JR, Rosenbloom FM, Kelley WN (1967) Enzym defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155: 1682–1684PubMedCrossRefGoogle Scholar
  247. Segura JW, Erickson SB, Wilson DM, Berg CJ van den, Smith LH (1981) Infected renal lithiasis: Results of long-term surgical and medical management. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 195–198Google Scholar
  248. Shah BG, Draper HH (1966) Depression of calcium absorption in parathyroid-ectomized rats. Am J Physiol 211: 963–966PubMedGoogle Scholar
  249. Sherwin AL, Beck IT, McKenna RD (1960) The course of Wilson’s disease (hepatolenticular degeneration) during pregnancy and after delivery. Canad Med Assoc 83: 160–166Google Scholar
  250. Silbermann HR (1967) A new approach to the treatment of uric acid stones with comments on xanthinuria and calculi. Mod Treatment 4: 531–538Google Scholar
  251. Simmonds HA (1956) Harnsteine bei Kindern. Münch Med Wochenschr 121: 1654–1656Google Scholar
  252. Simmonds HA (1979) Diskussionsbeitrag in: Proceedings 3rd International Symposion on Pursia: Metabolism in man, Madrid/Spain 1979Google Scholar
  253. Simmonds HA, Barrat TM, Webster DR, Sahota A, Acker KJ van, Cameron JS, Dillon M (1976) Spectrum of dihydroxyadenine urolithiasis in complete APRT deficiency. Purine metabolism in man. In: Rapado A, Watts RWE, Bruyn CHMM de (eds) Advances in ex- perimental medicine and biology. Plenum Press, New York London, p 337–341Google Scholar
  254. Smith AD, Lange PH, Miller RP, Reinke DB (1979) Dissolution of cystine calculi by imigation with acetylcysteine through percutaneous nephrostomy. J Urol 13: 422–423CrossRefGoogle Scholar
  255. Smith DR, Kolb FO, Harper HA (1959) Management of cystinuria and cystine-stone disease. J Urol 81: 61–64PubMedGoogle Scholar
  256. Smith L (1985) Effects of orthophosphates and ion binders. In: Schwille PO, Smith LH, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York and London, pp 483–489Google Scholar
  257. Smith MJ (1977) Placebo versus allopurinol for renal calculi. J Urol 117: 690–692PubMedGoogle Scholar
  258. Smith MJ, Boyce WH (1969) Allopurinol and urolithiasis. J Urol 102: 750–753PubMedGoogle Scholar
  259. Sonoda T, Kinoschita K, Kotake T, Sunao Y, Takenki N (1970) Effect of thiola on cystinuria. Proceedings Ist International Symposion Thiola, Sauten, Osaka 1970, p 231–234Google Scholar
  260. Sorenson L (1968) Seminars on the Lesh-Nyhan-Syndrom. Management and treatment, discussion. Fed Proc 27: 1099Google Scholar
  261. Sperling O, Vries A de (1964) Studies on the etiology of uric acid lithiasis. Part 2: Solubility of uric acid in urine specimens from normal subjects and patients with idiopathic uric acid lithiasis. J Urol 92: 331–334PubMedGoogle Scholar
  262. Stark H, Savir A (1980) Dissolution of cystine calculi by pelvic caliceal irrigation with D-penicillamin. J Urol 124: 895–898PubMedGoogle Scholar
  263. Sternlieb I (1966) Penicillamine and the nephrotic Syndrome. Results in patients with hepatolenticular degeneration. JAMA 198: 1311–1312PubMedCrossRefGoogle Scholar
  264. Suby HJ, Albright F (1943) Dissolution of phosphatic urinary calculi by the retrograde introduction of citrate Solution containing magnesium. N Engl J Med 228: 81–91CrossRefGoogle Scholar
  265. Sur BK, Pandey HN (1981) Effect of different urinary constituents on inhibiting or acceleration calcium Oxalate crystallisation. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 607–610Google Scholar
  266. Sutor DJ (1969) Growth studies of calcium oxalate in the presence of various ions and Compounds. Br J Urol 41: 171–178PubMedCrossRefGoogle Scholar
  267. Sy WA de, Osterlinck W (1981) Bidimensional radioscopy: A rapid method for peroperative localisation of residual calculi. In: Schulman CC (ed) Advances in diagnostic urology. Springer, Berlin Heidelberg New York, p 83–86Google Scholar
  268. Taccinoli M, Lotti T, Miano L, Laurenti C (1973) La calcolosi urinaria nell’infanzia. Relaz Uff 46 ° Congres Soc Ital UrolGoogle Scholar
  269. Terhorst B, Lutzeyer W (1973) Möglichkeiten der medikamentösen Oxalatsteinprophylaxe. Z Urol Nephrol 65: 815Google Scholar
  270. Terhorst B, Melchior HJ (1972) Die medikamentöse Behandlung des Harnsteinleidens. Urol Int 27: 230–244PubMedCrossRefGoogle Scholar
  271. Terhorst B, Stuhlsatz HW (1975) Cystinsteintherapie mit Mercaptopropionylglycine MPG. Urologe [Ausg A] 14: 190–193Google Scholar
  272. Tew WP, Malis CD, Lehninger AL, Walker GW, Howard JE (1981) Inhibition of PTH-induced nephrocalcinosis by phosphocitrate. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 559–568Google Scholar
  273. Thannhausers Lehrbuch des Stoffwechsels und der Stoffwechselkrankheiten, 2. Aufl. Herausgegeben von Zöllner N. Thieme, Stuttgart (1952)Google Scholar
  274. Thannhauser SJ (1956) Über die Pathogenese der Gicht. DMW 81: 492–496CrossRefGoogle Scholar
  275. Thomas J, Lemonnier A, Charpentier C, Lelne R, Melon J, Steg A, Aboulker P (1970) Lithiase cystinique — première résultats cliniques avec l’alpha-mercaptopropionylgylcine. Première Résultats biologiques avec le dithiosalicylate de sodium. J Urol Nephrol 76: 823–828Google Scholar
  276. Thomas J, Melon JM, Steg A, Aboulker P (1972) Traitement hyperoxalurique par le succinimide dans la lithiase oxalique renale de l’homme. Therapie 26: 999–1005Google Scholar
  277. Thomas J, Charpentier C, Thomas E (1976) Traitement de la lithiase cystinique par l’alphamercaptopropionylglycine. Therapie 31: 623–629PubMedGoogle Scholar
  278. Thomas WC (1978) Use of phosphates in patients with calcareous renal calculi. Kidney Int 13: 390–396PubMedCrossRefGoogle Scholar
  279. Timmermann A, Kallistratos G (1966) Modern aspects of chemical dissolution of human renal calculi by irrigation. J Urol 95: 469–475PubMedGoogle Scholar
  280. Timmermann A, Kallistratos G (1968) Gefahren und Kontraindikationen der instrumenteilen Nierensteinchemolyse. Urol Int 23: 236–243PubMedCrossRefGoogle Scholar
  281. Timmermann A, Kallistratos G (1973) Instrumentelle Nierensteinchemolyse. In: Hienzsch E, Schneider HJ (Hrsg) Der Harnstein. VEB Gustav Fischer, JenaGoogle Scholar
  282. Tiselius HG, Larson L (1981) Inhibition of calcium Oxalate crystal growth in patients with urolithiasis. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 623–629Google Scholar
  283. Toel F (1855) Beobachtungen über Cystinbildung. Ann Chem Pharmacol 96: 247–251CrossRefGoogle Scholar
  284. Troup CW, Lawnicki CC, Bourne RB, Hodgson NB (1972) Renal calculus in children. J Urol 107: 306–307PubMedGoogle Scholar
  285. Udransky L von, Boumann E (1889) Über das Vorkommen von Diaminen, sogenannten Ptomainen bei Cystinurie. Z Physiol Chemie 13: 562Google Scholar
  286. Vabusek M (1976) Zur Prophylaxe von Harnsteinen bei Hyperurikaemie und Gicht. In: Feldmann U, Mewes D (Hrsg) Urolithiasis. Straube, Erlangen, S 162–165Google Scholar
  287. Vahlensieck W (1976) Diät beim Harnsteinleiden. Infusionstherapie 3: 243–248Google Scholar
  288. Vahlensieck W (1980) Kindliche Harnsteine. In: Hautmann R, Lutzeyer W (Hrsg) Harnsteinfibel. Deutscher Ärzteverlag, Köln, S 211–218Google Scholar
  289. Vries A de, Sperling O (1976) Uric acid stone formation: Basic concepts of etiology and treatment. In: Williams DI, Chisholm GD (eds) Scientific foundation of urology. Heinemann Medical Books, London, p 297–302Google Scholar
  290. Vries A de, Frank M, Atsmon A (1962) Inherited uric acid lithiasis. Am J Med 33: 880–886PubMedCrossRefGoogle Scholar
  291. Wallace SL (1978) The treatment of gout, arthritis. Rheum 15: 317–332Google Scholar
  292. Watts RWE (1973) Oxalate biosynthesis in primary hyperoxaluria. Internationales Harnstein-Symposion, Madrid 1972. In: Cifuentes-Delatte L, Rapado A, Hodgkinson A (eds) Urinary calculi. Karger, Basel, p 13–17Google Scholar
  293. Watts RWE, Watkins PJ, Matthias JQ, Gibbs DA (1966) Allopurinol and acute uric acid nephropathy. Br Med J 1: 205–208PubMedCrossRefGoogle Scholar
  294. Wellhöner HH (1976) Allgemeine und systematische Pharmakologie und Toxikologie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  295. Westenfelder M, Galanos C, Madsen PO (1975) Experimental lipid. A induced nephritis in the dog. Invest Urol 5: 337–345Google Scholar
  296. Wilkinson R (1976) Absorption of calcium, phosphorus and magnesium. In: Nordin BEC (ed) Calcium phosphate and magnesium metabolism. Churchill-Livingstone, Edinburgh, p 36–112Google Scholar
  297. Williams G, Sallis JD (1981) The sources of phosphocitrate and its role as an inhibitor of calcium phosphate and calcium Oxalate crystallisation. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis. Plenum Press, New York London, p 569–577Google Scholar
  298. Williams HE (1974) Calcium nephrolithiasis and cellulose phosphate. N Engl J Med 290: 224PubMedCrossRefGoogle Scholar
  299. Williams HE (1976) Oxalsäure: Absorption, Exkretion and Mebabolismus. Internationales Symposion, Davos 1976. In: Feldmann U, Newes D (Hrsg) Urolithiasis. Straube Erlangen, S 87–91Google Scholar
  300. Williams HE (1977) The causes of kidney stones — their diagnosis and treatment. Med Times 105: 55–59PubMedGoogle Scholar
  301. Williams HE, Smith LH jr (1968) Primary hyperoxaluria. Am J Med 45: 196–219CrossRefGoogle Scholar
  302. Williams HE, Johnson GA, Smith LH (1971) The renal clearance of Oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci 41: 213–218PubMedGoogle Scholar
  303. Willnow U (1968) Nephrolithiasis im Säuglings- und Kindesalter. DMW 92: 1668–1674CrossRefGoogle Scholar
  304. Wolf M (1969) Kationenaustauscher als Diuretica. In: Herken H (Hrsg) Diuretica. Springer, Berlin Heidelberg New York ( Handbuch der experimentellen Pharmakologie, Bd XXIV, S 574–593 )Google Scholar
  305. Wolff HP (1954) Die Therapie mit Kationenaustauschern im Lichte fünfjähriger Erfahrung. Klin Wochenschr 32: 761–770PubMedCrossRefGoogle Scholar
  306. Wollaston WH (1810) On cystic oxide, a new species of urinary calculus. Philos Trans R Soc Lond [Biol] 100: 223–230CrossRefGoogle Scholar
  307. Worthmann RL, Kelly WN (1977) Gout and hyperuricemia: A rational approach to management. Clin Ther 1: 159–184Google Scholar
  308. Wrong O, Davies HEF (1959) The excretion of acid in renal disease. Q J Med 28: 259–363PubMedGoogle Scholar
  309. Yendt ER (1985) Effects of thiazides. Vth International Symposion on urolithiasis and related clinical research, 1984. Plenum Press, New York (in press)Google Scholar
  310. Yendt ER, Cohanim M (1973) Ten years experience with the use of thiazides in the prevention of kidney stones. Am Clin Climat Assoc 85: 65–75Google Scholar
  311. Yendt ER, Gagné RJA, Cohanim M (1966) The effect of thiazides on idopathic hypercalcuria. Am J Med Sei 251: 449–460CrossRefGoogle Scholar
  312. Yü TF (1965) Secondary gout associated with myeloproliferative diseases. Arthritis Rheum 8: 765–771PubMedCrossRefGoogle Scholar
  313. Yü TF (1974) Milestones in the treatment of gout. Am J Med 56: 673–677CrossRefGoogle Scholar
  314. Yü TF, Gutman AB (1964) Effect of allopurinol (4-hydroxypyrazol[3,4-d]pyrimidine) on serum and urinary uric acid in primary and secondary gout. Am J Med 37: 885–898CrossRefGoogle Scholar
  315. Zarembski PM, Hodgkinson A (1969) Some factors influencing the urinary excretion of oxalic in man. Clin Chir Act 25: 1–10CrossRefGoogle Scholar
  316. Zechner O, Latal D, Grundig E, Muller M (1976) Klinische Aspekte der Cystinurie und ihre Behandlung mit Thiola. Wien Klin Wochenschr 88: 101–105PubMedGoogle Scholar
  317. Zilleken F (1975) Wirkungsweise des Succinimids im Intermediärstoffwechsel. Symposium zur Succinimidtherapie, veranstaltet von der Firma Medice, Iserlohn 1975Google Scholar
  318. Zinnemann HH, Jones JE (1960) Dietary methionine and its influence on cystine excretion in cystinuric patients. Metabolism 15: 915–921CrossRefGoogle Scholar
  319. Zöllner N (1960) Moderne Gichtprobleme. Ergeb Inn Med Kinderheilk 14: 321–389Google Scholar
  320. Zöllner N, Griebsch A (1973) Influence of various dietary purines on uric acid produetion. International Symposion on renal stone research, Madrid 1973, p 84–88Google Scholar
  321. Zöllner N, Schattenkirchner M (1967) Allopurinol in der Behandlung der Gicht und der Harnsäurenephrolithiasis. DMW 92: 654–660CrossRefGoogle Scholar
  322. Zöllner N, Griebsch A, Gröbner W (1972) Einfluß verschiedener Purine auf den Harnsäurestoffwechsel. Ernährungsumschau 3: 79–82Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • W. Lutzeyer
  • F. Hering

There are no affiliations available

Personalised recommendations